nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—SIGMAR1—Tamoxifen—pancreatic cancer	0.363	0.59	CbGbCtD
Amantadine—ABCB1—Tamoxifen—pancreatic cancer	0.0504	0.0817	CbGbCtD
Amantadine—ABCB1—Gemcitabine—pancreatic cancer	0.0434	0.0704	CbGbCtD
Amantadine—ABCB1—Erlotinib—pancreatic cancer	0.0428	0.0695	CbGbCtD
Amantadine—ABCB1—Irinotecan—pancreatic cancer	0.0387	0.0627	CbGbCtD
Amantadine—ABCB1—Docetaxel—pancreatic cancer	0.0283	0.046	CbGbCtD
Amantadine—ABCB1—Sunitinib—pancreatic cancer	0.0282	0.0458	CbGbCtD
Amantadine—ABCB1—Doxorubicin—pancreatic cancer	0.0211	0.0343	CbGbCtD
Amantadine—Hypotension—Irinotecan—pancreatic cancer	0.00053	0.00172	CcSEcCtD
Amantadine—Anorexia—Gemcitabine—pancreatic cancer	0.000527	0.00171	CcSEcCtD
Amantadine—Dizziness—Erlotinib—pancreatic cancer	0.000526	0.00171	CcSEcCtD
Amantadine—Anorexia—Fluorouracil—pancreatic cancer	0.000518	0.00169	CcSEcCtD
Amantadine—Hypotension—Gemcitabine—pancreatic cancer	0.000517	0.00168	CcSEcCtD
Amantadine—Eye disorder—Docetaxel—pancreatic cancer	0.000516	0.00168	CcSEcCtD
Amantadine—Insomnia—Irinotecan—pancreatic cancer	0.000513	0.00167	CcSEcCtD
Amantadine—Cardiac disorder—Docetaxel—pancreatic cancer	0.000513	0.00167	CcSEcCtD
Amantadine—Cardiac arrest—Epirubicin—pancreatic cancer	0.000512	0.00167	CcSEcCtD
Amantadine—Vomiting—Tamoxifen—pancreatic cancer	0.000512	0.00166	CcSEcCtD
Amantadine—Cardiac failure—Doxorubicin—pancreatic cancer	0.000511	0.00166	CcSEcCtD
Amantadine—Paraesthesia—Irinotecan—pancreatic cancer	0.00051	0.00166	CcSEcCtD
Amantadine—Lethargy—Doxorubicin—pancreatic cancer	0.000509	0.00165	CcSEcCtD
Amantadine—Hypotension—Fluorouracil—pancreatic cancer	0.000508	0.00165	CcSEcCtD
Amantadine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000508	0.00165	CcSEcCtD
Amantadine—Rash—Tamoxifen—pancreatic cancer	0.000507	0.00165	CcSEcCtD
Amantadine—Dermatitis—Tamoxifen—pancreatic cancer	0.000507	0.00165	CcSEcCtD
Amantadine—Ataxia—Epirubicin—pancreatic cancer	0.000506	0.00165	CcSEcCtD
Amantadine—Vomiting—Erlotinib—pancreatic cancer	0.000506	0.00165	CcSEcCtD
Amantadine—Dyspnoea—Irinotecan—pancreatic cancer	0.000506	0.00165	CcSEcCtD
Amantadine—Somnolence—Irinotecan—pancreatic cancer	0.000505	0.00164	CcSEcCtD
Amantadine—Headache—Tamoxifen—pancreatic cancer	0.000504	0.00164	CcSEcCtD
Amantadine—Rash—Erlotinib—pancreatic cancer	0.000502	0.00163	CcSEcCtD
Amantadine—Dermatitis—Erlotinib—pancreatic cancer	0.000501	0.00163	CcSEcCtD
Amantadine—Angiopathy—Docetaxel—pancreatic cancer	0.000501	0.00163	CcSEcCtD
Amantadine—Insomnia—Gemcitabine—pancreatic cancer	0.0005	0.00163	CcSEcCtD
Amantadine—Dyspepsia—Irinotecan—pancreatic cancer	0.0005	0.00162	CcSEcCtD
Amantadine—Headache—Erlotinib—pancreatic cancer	0.000499	0.00162	CcSEcCtD
Amantadine—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000498	0.00162	CcSEcCtD
Amantadine—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000498	0.00162	CcSEcCtD
Amantadine—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000497	0.00162	CcSEcCtD
Amantadine—Paraesthesia—Gemcitabine—pancreatic cancer	0.000497	0.00161	CcSEcCtD
Amantadine—Asthenia—Sunitinib—pancreatic cancer	0.000494	0.00161	CcSEcCtD
Amantadine—Decreased appetite—Irinotecan—pancreatic cancer	0.000493	0.0016	CcSEcCtD
Amantadine—Arrhythmia—Docetaxel—pancreatic cancer	0.000493	0.0016	CcSEcCtD
Amantadine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000493	0.0016	CcSEcCtD
Amantadine—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000492	0.0016	CcSEcCtD
Amantadine—Insomnia—Fluorouracil—pancreatic cancer	0.000492	0.0016	CcSEcCtD
Amantadine—Somnolence—Gemcitabine—pancreatic cancer	0.000492	0.0016	CcSEcCtD
Amantadine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00049	0.00159	CcSEcCtD
Amantadine—Fatigue—Irinotecan—pancreatic cancer	0.000489	0.00159	CcSEcCtD
Amantadine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000488	0.00159	CcSEcCtD
Amantadine—Alopecia—Docetaxel—pancreatic cancer	0.000488	0.00159	CcSEcCtD
Amantadine—Pruritus—Sunitinib—pancreatic cancer	0.000488	0.00159	CcSEcCtD
Amantadine—Constipation—Irinotecan—pancreatic cancer	0.000485	0.00158	CcSEcCtD
Amantadine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000485	0.00158	CcSEcCtD
Amantadine—Mental disorder—Docetaxel—pancreatic cancer	0.000484	0.00157	CcSEcCtD
Amantadine—Somnolence—Fluorouracil—pancreatic cancer	0.000483	0.00157	CcSEcCtD
Amantadine—Malnutrition—Docetaxel—pancreatic cancer	0.000481	0.00156	CcSEcCtD
Amantadine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000481	0.00156	CcSEcCtD
Amantadine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000479	0.00156	CcSEcCtD
Amantadine—Nausea—Tamoxifen—pancreatic cancer	0.000478	0.00155	CcSEcCtD
Amantadine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000477	0.00155	CcSEcCtD
Amantadine—Fatigue—Gemcitabine—pancreatic cancer	0.000477	0.00155	CcSEcCtD
Amantadine—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000474	0.00154	CcSEcCtD
Amantadine—Constipation—Gemcitabine—pancreatic cancer	0.000473	0.00154	CcSEcCtD
Amantadine—Nausea—Erlotinib—pancreatic cancer	0.000473	0.00154	CcSEcCtD
Amantadine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000473	0.00154	CcSEcCtD
Amantadine—Diarrhoea—Sunitinib—pancreatic cancer	0.000472	0.00153	CcSEcCtD
Amantadine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000469	0.00153	CcSEcCtD
Amantadine—Ataxia—Doxorubicin—pancreatic cancer	0.000469	0.00152	CcSEcCtD
Amantadine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000468	0.00152	CcSEcCtD
Amantadine—Dysphagia—Epirubicin—pancreatic cancer	0.000465	0.00151	CcSEcCtD
Amantadine—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.00046	0.0015	CcSEcCtD
Amantadine—Dizziness—Sunitinib—pancreatic cancer	0.000456	0.00148	CcSEcCtD
Amantadine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000456	0.00148	CcSEcCtD
Amantadine—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000455	0.00148	CcSEcCtD
Amantadine—Body temperature increased—Irinotecan—pancreatic cancer	0.000449	0.00146	CcSEcCtD
Amantadine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000448	0.00146	CcSEcCtD
Amantadine—Vomiting—Sunitinib—pancreatic cancer	0.000438	0.00142	CcSEcCtD
Amantadine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000437	0.00142	CcSEcCtD
Amantadine—Neutropenia—Epirubicin—pancreatic cancer	0.000435	0.00142	CcSEcCtD
Amantadine—Rash—Sunitinib—pancreatic cancer	0.000435	0.00141	CcSEcCtD
Amantadine—Dermatitis—Sunitinib—pancreatic cancer	0.000434	0.00141	CcSEcCtD
Amantadine—Headache—Sunitinib—pancreatic cancer	0.000432	0.0014	CcSEcCtD
Amantadine—Dysphagia—Doxorubicin—pancreatic cancer	0.000431	0.0014	CcSEcCtD
Amantadine—Leukopenia—Docetaxel—pancreatic cancer	0.00043	0.0014	CcSEcCtD
Amantadine—Body temperature increased—Fluorouracil—pancreatic cancer	0.00043	0.0014	CcSEcCtD
Amantadine—Palpitations—Docetaxel—pancreatic cancer	0.000425	0.00138	CcSEcCtD
Amantadine—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000425	0.00138	CcSEcCtD
Amantadine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000418	0.00136	CcSEcCtD
Amantadine—Convulsion—Docetaxel—pancreatic cancer	0.000417	0.00135	CcSEcCtD
Amantadine—Hypertension—Docetaxel—pancreatic cancer	0.000415	0.00135	CcSEcCtD
Amantadine—Nausea—Sunitinib—pancreatic cancer	0.000409	0.00133	CcSEcCtD
Amantadine—Asthenia—Irinotecan—pancreatic cancer	0.000407	0.00132	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000407	0.00132	CcSEcCtD
Amantadine—Neutropenia—Doxorubicin—pancreatic cancer	0.000403	0.00131	CcSEcCtD
Amantadine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000401	0.0013	CcSEcCtD
Amantadine—Dry mouth—Docetaxel—pancreatic cancer	0.0004	0.0013	CcSEcCtD
Amantadine—Asthenia—Gemcitabine—pancreatic cancer	0.000397	0.00129	CcSEcCtD
Amantadine—Confusional state—Docetaxel—pancreatic cancer	0.000396	0.00129	CcSEcCtD
Amantadine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000393	0.00128	CcSEcCtD
Amantadine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000392	0.00128	CcSEcCtD
Amantadine—Oedema—Docetaxel—pancreatic cancer	0.000392	0.00128	CcSEcCtD
Amantadine—Pruritus—Gemcitabine—pancreatic cancer	0.000391	0.00127	CcSEcCtD
Amantadine—Diarrhoea—Irinotecan—pancreatic cancer	0.000388	0.00126	CcSEcCtD
Amantadine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000387	0.00126	CcSEcCtD
Amantadine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000385	0.00125	CcSEcCtD
Amantadine—Pruritus—Fluorouracil—pancreatic cancer	0.000385	0.00125	CcSEcCtD
Amantadine—Tachycardia—Docetaxel—pancreatic cancer	0.000383	0.00125	CcSEcCtD
Amantadine—Skin disorder—Docetaxel—pancreatic cancer	0.000381	0.00124	CcSEcCtD
Amantadine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000378	0.00123	CcSEcCtD
Amantadine—Dizziness—Irinotecan—pancreatic cancer	0.000375	0.00122	CcSEcCtD
Amantadine—Anorexia—Docetaxel—pancreatic cancer	0.000374	0.00122	CcSEcCtD
Amantadine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000372	0.00121	CcSEcCtD
Amantadine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000368	0.0012	CcSEcCtD
Amantadine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000367	0.00119	CcSEcCtD
Amantadine—Hypotension—Docetaxel—pancreatic cancer	0.000367	0.00119	CcSEcCtD
Amantadine—Urethral disorder—Epirubicin—pancreatic cancer	0.000365	0.00119	CcSEcCtD
Amantadine—Vomiting—Irinotecan—pancreatic cancer	0.000361	0.00117	CcSEcCtD
Amantadine—Dizziness—Fluorouracil—pancreatic cancer	0.00036	0.00117	CcSEcCtD
Amantadine—Visual impairment—Epirubicin—pancreatic cancer	0.000359	0.00117	CcSEcCtD
Amantadine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000358	0.00117	CcSEcCtD
Amantadine—Rash—Irinotecan—pancreatic cancer	0.000358	0.00116	CcSEcCtD
Amantadine—Dermatitis—Irinotecan—pancreatic cancer	0.000358	0.00116	CcSEcCtD
Amantadine—Headache—Irinotecan—pancreatic cancer	0.000356	0.00116	CcSEcCtD
Amantadine—Insomnia—Docetaxel—pancreatic cancer	0.000355	0.00115	CcSEcCtD
Amantadine—Paraesthesia—Docetaxel—pancreatic cancer	0.000352	0.00115	CcSEcCtD
Amantadine—Vomiting—Gemcitabine—pancreatic cancer	0.000352	0.00114	CcSEcCtD
Amantadine—Dyspnoea—Docetaxel—pancreatic cancer	0.00035	0.00114	CcSEcCtD
Amantadine—Somnolence—Docetaxel—pancreatic cancer	0.000349	0.00113	CcSEcCtD
Amantadine—Rash—Gemcitabine—pancreatic cancer	0.000349	0.00113	CcSEcCtD
Amantadine—Dermatitis—Gemcitabine—pancreatic cancer	0.000348	0.00113	CcSEcCtD
Amantadine—Eye disorder—Epirubicin—pancreatic cancer	0.000348	0.00113	CcSEcCtD
Amantadine—Headache—Gemcitabine—pancreatic cancer	0.000346	0.00113	CcSEcCtD
Amantadine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000346	0.00112	CcSEcCtD
Amantadine—Vomiting—Fluorouracil—pancreatic cancer	0.000346	0.00112	CcSEcCtD
Amantadine—Dyspepsia—Docetaxel—pancreatic cancer	0.000345	0.00112	CcSEcCtD
Amantadine—Rash—Fluorouracil—pancreatic cancer	0.000343	0.00111	CcSEcCtD
Amantadine—Dermatitis—Fluorouracil—pancreatic cancer	0.000342	0.00111	CcSEcCtD
Amantadine—Decreased appetite—Docetaxel—pancreatic cancer	0.000341	0.00111	CcSEcCtD
Amantadine—Headache—Fluorouracil—pancreatic cancer	0.000341	0.00111	CcSEcCtD
Amantadine—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.00034	0.00111	CcSEcCtD
Amantadine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.00034	0.0011	CcSEcCtD
Amantadine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000339	0.0011	CcSEcCtD
Amantadine—Fatigue—Docetaxel—pancreatic cancer	0.000338	0.0011	CcSEcCtD
Amantadine—Angiopathy—Epirubicin—pancreatic cancer	0.000338	0.0011	CcSEcCtD
Amantadine—Urethral disorder—Doxorubicin—pancreatic cancer	0.000338	0.0011	CcSEcCtD
Amantadine—Nausea—Irinotecan—pancreatic cancer	0.000337	0.0011	CcSEcCtD
Amantadine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000336	0.00109	CcSEcCtD
Amantadine—Constipation—Docetaxel—pancreatic cancer	0.000336	0.00109	CcSEcCtD
Amantadine—Arrhythmia—Epirubicin—pancreatic cancer	0.000333	0.00108	CcSEcCtD
Amantadine—Visual impairment—Doxorubicin—pancreatic cancer	0.000332	0.00108	CcSEcCtD
Amantadine—Alopecia—Epirubicin—pancreatic cancer	0.000329	0.00107	CcSEcCtD
Amantadine—Nausea—Gemcitabine—pancreatic cancer	0.000328	0.00107	CcSEcCtD
Amantadine—Mental disorder—Epirubicin—pancreatic cancer	0.000326	0.00106	CcSEcCtD
Amantadine—Malnutrition—Epirubicin—pancreatic cancer	0.000324	0.00105	CcSEcCtD
Amantadine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000323	0.00105	CcSEcCtD
Amantadine—Nausea—Fluorouracil—pancreatic cancer	0.000323	0.00105	CcSEcCtD
Amantadine—Eye disorder—Doxorubicin—pancreatic cancer	0.000322	0.00105	CcSEcCtD
Amantadine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.00032	0.00104	CcSEcCtD
Amantadine—Tension—Epirubicin—pancreatic cancer	0.000318	0.00103	CcSEcCtD
Amantadine—Nervousness—Epirubicin—pancreatic cancer	0.000315	0.00102	CcSEcCtD
Amantadine—Angiopathy—Doxorubicin—pancreatic cancer	0.000313	0.00102	CcSEcCtD
Amantadine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000311	0.00101	CcSEcCtD
Amantadine—Body temperature increased—Docetaxel—pancreatic cancer	0.00031	0.00101	CcSEcCtD
Amantadine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000308	0.001	CcSEcCtD
Amantadine—Vision blurred—Epirubicin—pancreatic cancer	0.000306	0.000994	CcSEcCtD
Amantadine—Alopecia—Doxorubicin—pancreatic cancer	0.000305	0.000991	CcSEcCtD
Amantadine—Mental disorder—Doxorubicin—pancreatic cancer	0.000302	0.000982	CcSEcCtD
Amantadine—Malnutrition—Doxorubicin—pancreatic cancer	0.0003	0.000976	CcSEcCtD
Amantadine—Agitation—Epirubicin—pancreatic cancer	0.000298	0.000969	CcSEcCtD
Amantadine—Tension—Doxorubicin—pancreatic cancer	0.000294	0.000958	CcSEcCtD
Amantadine—Nervousness—Doxorubicin—pancreatic cancer	0.000291	0.000948	CcSEcCtD
Amantadine—Leukopenia—Epirubicin—pancreatic cancer	0.00029	0.000944	CcSEcCtD
Amantadine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000289	0.00094	CcSEcCtD
Amantadine—Palpitations—Epirubicin—pancreatic cancer	0.000287	0.000932	CcSEcCtD
Amantadine—Vision blurred—Doxorubicin—pancreatic cancer	0.000283	0.00092	CcSEcCtD
Amantadine—Asthenia—Docetaxel—pancreatic cancer	0.000282	0.000916	CcSEcCtD
Amantadine—Convulsion—Epirubicin—pancreatic cancer	0.000281	0.000914	CcSEcCtD
Amantadine—Hypertension—Epirubicin—pancreatic cancer	0.00028	0.00091	CcSEcCtD
Amantadine—Pruritus—Docetaxel—pancreatic cancer	0.000278	0.000903	CcSEcCtD
Amantadine—Agitation—Doxorubicin—pancreatic cancer	0.000276	0.000897	CcSEcCtD
Amantadine—Anxiety—Epirubicin—pancreatic cancer	0.000275	0.000895	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000274	0.000892	CcSEcCtD
Amantadine—Dry mouth—Epirubicin—pancreatic cancer	0.00027	0.000878	CcSEcCtD
Amantadine—Leukopenia—Doxorubicin—pancreatic cancer	0.000269	0.000873	CcSEcCtD
Amantadine—Diarrhoea—Docetaxel—pancreatic cancer	0.000269	0.000873	CcSEcCtD
Amantadine—Confusional state—Epirubicin—pancreatic cancer	0.000267	0.000868	CcSEcCtD
Amantadine—Palpitations—Doxorubicin—pancreatic cancer	0.000265	0.000862	CcSEcCtD
Amantadine—Oedema—Epirubicin—pancreatic cancer	0.000265	0.000861	CcSEcCtD
Amantadine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000265	0.000861	CcSEcCtD
Amantadine—Convulsion—Doxorubicin—pancreatic cancer	0.00026	0.000845	CcSEcCtD
Amantadine—Nervous system disorder—Epirubicin—pancreatic cancer	0.00026	0.000844	CcSEcCtD
Amantadine—Dizziness—Docetaxel—pancreatic cancer	0.00026	0.000844	CcSEcCtD
Amantadine—Hypertension—Doxorubicin—pancreatic cancer	0.000259	0.000842	CcSEcCtD
Amantadine—Tachycardia—Epirubicin—pancreatic cancer	0.000258	0.00084	CcSEcCtD
Amantadine—Skin disorder—Epirubicin—pancreatic cancer	0.000257	0.000836	CcSEcCtD
Amantadine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000256	0.000832	CcSEcCtD
Amantadine—Anxiety—Doxorubicin—pancreatic cancer	0.000255	0.000828	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000254	0.000825	CcSEcCtD
Amantadine—Anorexia—Epirubicin—pancreatic cancer	0.000252	0.00082	CcSEcCtD
Amantadine—Dry mouth—Doxorubicin—pancreatic cancer	0.00025	0.000812	CcSEcCtD
Amantadine—Vomiting—Docetaxel—pancreatic cancer	0.00025	0.000811	CcSEcCtD
Amantadine—Rash—Docetaxel—pancreatic cancer	0.000247	0.000805	CcSEcCtD
Amantadine—Hypotension—Epirubicin—pancreatic cancer	0.000247	0.000804	CcSEcCtD
Amantadine—Dermatitis—Docetaxel—pancreatic cancer	0.000247	0.000804	CcSEcCtD
Amantadine—Confusional state—Doxorubicin—pancreatic cancer	0.000247	0.000803	CcSEcCtD
Amantadine—Headache—Docetaxel—pancreatic cancer	0.000246	0.000799	CcSEcCtD
Amantadine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000245	0.000796	CcSEcCtD
Amantadine—Oedema—Doxorubicin—pancreatic cancer	0.000245	0.000796	CcSEcCtD
Amantadine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00024	0.000781	CcSEcCtD
Amantadine—Insomnia—Epirubicin—pancreatic cancer	0.000239	0.000778	CcSEcCtD
Amantadine—Tachycardia—Doxorubicin—pancreatic cancer	0.000239	0.000777	CcSEcCtD
Amantadine—Skin disorder—Doxorubicin—pancreatic cancer	0.000238	0.000774	CcSEcCtD
Amantadine—Paraesthesia—Epirubicin—pancreatic cancer	0.000238	0.000773	CcSEcCtD
Amantadine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000237	0.00077	CcSEcCtD
Amantadine—Dyspnoea—Epirubicin—pancreatic cancer	0.000236	0.000767	CcSEcCtD
Amantadine—Somnolence—Epirubicin—pancreatic cancer	0.000235	0.000765	CcSEcCtD
Amantadine—Anorexia—Doxorubicin—pancreatic cancer	0.000233	0.000759	CcSEcCtD
Amantadine—Nausea—Docetaxel—pancreatic cancer	0.000233	0.000758	CcSEcCtD
Amantadine—Dyspepsia—Epirubicin—pancreatic cancer	0.000233	0.000758	CcSEcCtD
Amantadine—Decreased appetite—Epirubicin—pancreatic cancer	0.00023	0.000748	CcSEcCtD
Amantadine—Hypotension—Doxorubicin—pancreatic cancer	0.000229	0.000744	CcSEcCtD
Amantadine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000229	0.000743	CcSEcCtD
Amantadine—Fatigue—Epirubicin—pancreatic cancer	0.000228	0.000742	CcSEcCtD
Amantadine—Constipation—Epirubicin—pancreatic cancer	0.000226	0.000736	CcSEcCtD
Amantadine—Insomnia—Doxorubicin—pancreatic cancer	0.000222	0.00072	CcSEcCtD
Amantadine—Paraesthesia—Doxorubicin—pancreatic cancer	0.00022	0.000715	CcSEcCtD
Amantadine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000218	0.00071	CcSEcCtD
Amantadine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000218	0.000709	CcSEcCtD
Amantadine—Somnolence—Doxorubicin—pancreatic cancer	0.000218	0.000708	CcSEcCtD
Amantadine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000216	0.000701	CcSEcCtD
Amantadine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000213	0.000692	CcSEcCtD
Amantadine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000211	0.000688	CcSEcCtD
Amantadine—Fatigue—Doxorubicin—pancreatic cancer	0.000211	0.000687	CcSEcCtD
Amantadine—Constipation—Doxorubicin—pancreatic cancer	0.000209	0.000681	CcSEcCtD
Amantadine—Body temperature increased—Epirubicin—pancreatic cancer	0.000209	0.00068	CcSEcCtD
Amantadine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000202	0.000656	CcSEcCtD
Amantadine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000195	0.000634	CcSEcCtD
Amantadine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000194	0.00063	CcSEcCtD
Amantadine—Asthenia—Epirubicin—pancreatic cancer	0.00019	0.000618	CcSEcCtD
Amantadine—Pruritus—Epirubicin—pancreatic cancer	0.000187	0.000609	CcSEcCtD
Amantadine—Diarrhoea—Epirubicin—pancreatic cancer	0.000181	0.000589	CcSEcCtD
Amantadine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00018	0.000587	CcSEcCtD
Amantadine—Asthenia—Doxorubicin—pancreatic cancer	0.000176	0.000571	CcSEcCtD
Amantadine—Dizziness—Epirubicin—pancreatic cancer	0.000175	0.000569	CcSEcCtD
Amantadine—Pruritus—Doxorubicin—pancreatic cancer	0.000173	0.000563	CcSEcCtD
Amantadine—Vomiting—Epirubicin—pancreatic cancer	0.000168	0.000547	CcSEcCtD
Amantadine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000168	0.000545	CcSEcCtD
Amantadine—Rash—Epirubicin—pancreatic cancer	0.000167	0.000543	CcSEcCtD
Amantadine—Dermatitis—Epirubicin—pancreatic cancer	0.000167	0.000542	CcSEcCtD
Amantadine—Headache—Epirubicin—pancreatic cancer	0.000166	0.000539	CcSEcCtD
Amantadine—Dizziness—Doxorubicin—pancreatic cancer	0.000162	0.000527	CcSEcCtD
Amantadine—Nausea—Epirubicin—pancreatic cancer	0.000157	0.000511	CcSEcCtD
Amantadine—Vomiting—Doxorubicin—pancreatic cancer	0.000156	0.000506	CcSEcCtD
Amantadine—Rash—Doxorubicin—pancreatic cancer	0.000154	0.000502	CcSEcCtD
Amantadine—Dermatitis—Doxorubicin—pancreatic cancer	0.000154	0.000502	CcSEcCtD
Amantadine—Headache—Doxorubicin—pancreatic cancer	0.000153	0.000499	CcSEcCtD
Amantadine—Nausea—Doxorubicin—pancreatic cancer	0.000145	0.000473	CcSEcCtD
Amantadine—SLC22A1—Metabolism—PRSS1—pancreatic cancer	6.13e-05	0.000805	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—EGFR—pancreatic cancer	6.03e-05	0.000792	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—SCT—pancreatic cancer	5.95e-05	0.000781	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	5.89e-05	0.000773	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—EGFR—pancreatic cancer	5.88e-05	0.000772	CbGpPWpGaD
Amantadine—DDC—Metabolism—STK11—pancreatic cancer	5.86e-05	0.00077	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ARG2—pancreatic cancer	5.7e-05	0.000749	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—KRAS—pancreatic cancer	5.7e-05	0.000748	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GAST—pancreatic cancer	5.7e-05	0.000748	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CCK—pancreatic cancer	5.67e-05	0.000745	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—KRAS—pancreatic cancer	5.55e-05	0.000729	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CNR2—pancreatic cancer	5.53e-05	0.000726	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—GLP1R—pancreatic cancer	5.53e-05	0.000726	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CD44—pancreatic cancer	5.48e-05	0.000719	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—HRAS—pancreatic cancer	5.46e-05	0.000717	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CCKAR—pancreatic cancer	5.44e-05	0.000714	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—CTNNB1—pancreatic cancer	5.43e-05	0.000713	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	5.4e-05	0.000709	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—SCT—pancreatic cancer	5.4e-05	0.000709	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—MMP9—pancreatic cancer	5.33e-05	0.000699	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—HRAS—pancreatic cancer	5.32e-05	0.000699	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ARG2—pancreatic cancer	5.32e-05	0.000698	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—CTNNB1—pancreatic cancer	5.3e-05	0.000695	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GCG—pancreatic cancer	5.25e-05	0.000689	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—MMP9—pancreatic cancer	5.19e-05	0.000682	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PRLHR—pancreatic cancer	5.16e-05	0.000678	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CCK—pancreatic cancer	5.15e-05	0.000676	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—TNF—pancreatic cancer	5.05e-05	0.000662	CbGpPWpGaD
Amantadine—DDC—Metabolism—TYMS—pancreatic cancer	5.04e-05	0.000662	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CNR2—pancreatic cancer	5.02e-05	0.000659	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GLP1R—pancreatic cancer	5.02e-05	0.000659	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	5.02e-05	0.000659	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—PTEN—pancreatic cancer	4.99e-05	0.000655	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—TYMP—pancreatic cancer	4.99e-05	0.000655	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CCKAR—pancreatic cancer	4.94e-05	0.000648	CbGpPWpGaD
Amantadine—MAOB—Metabolism—STK11—pancreatic cancer	4.94e-05	0.000648	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—SRC—pancreatic cancer	4.91e-05	0.000645	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—IAPP—pancreatic cancer	4.9e-05	0.000643	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—CXCL8—pancreatic cancer	4.89e-05	0.000643	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ACVR1B—pancreatic cancer	4.85e-05	0.000637	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ZNRF3—pancreatic cancer	4.85e-05	0.000637	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—HRAS—pancreatic cancer	4.84e-05	0.000636	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	4.8e-05	0.00063	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—SRC—pancreatic cancer	4.79e-05	0.000629	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—VEGFA—pancreatic cancer	4.78e-05	0.000628	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—STAT3—pancreatic cancer	4.74e-05	0.000622	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—NRAS—pancreatic cancer	4.72e-05	0.00062	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—HRAS—pancreatic cancer	4.72e-05	0.00062	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PTHLH—pancreatic cancer	4.7e-05	0.000617	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—VEGFA—pancreatic cancer	4.66e-05	0.000612	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—TYMP—pancreatic cancer	4.65e-05	0.00061	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—STAT3—pancreatic cancer	4.62e-05	0.000606	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—NRAS—pancreatic cancer	4.6e-05	0.000605	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—SHH—pancreatic cancer	4.5e-05	0.000591	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IAPP—pancreatic cancer	4.45e-05	0.000584	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SSTR3—pancreatic cancer	4.39e-05	0.000576	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—DTX1—pancreatic cancer	4.39e-05	0.000576	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—TGFB1—pancreatic cancer	4.39e-05	0.000576	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.38e-05	0.000575	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	4.34e-05	0.000569	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—EGFR—pancreatic cancer	4.3e-05	0.000565	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—SST—pancreatic cancer	4.3e-05	0.000564	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—TGFB1—pancreatic cancer	4.28e-05	0.000562	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PTHLH—pancreatic cancer	4.27e-05	0.00056	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PTCH1—pancreatic cancer	4.27e-05	0.00056	CbGpPWpGaD
Amantadine—MAOB—Metabolism—TYMS—pancreatic cancer	4.25e-05	0.000557	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SSTR1—pancreatic cancer	4.21e-05	0.000553	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—EGFR—pancreatic cancer	4.2e-05	0.000551	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PPY—pancreatic cancer	4.13e-05	0.000542	CbGpPWpGaD
Amantadine—DDC—Metabolism—APOE—pancreatic cancer	4.1e-05	0.000539	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—TNF—pancreatic cancer	4.1e-05	0.000538	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—KRAS—pancreatic cancer	4.07e-05	0.000534	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SSTR2—pancreatic cancer	4.05e-05	0.000532	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GLP1R—pancreatic cancer	4.02e-05	0.000528	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—TNF—pancreatic cancer	4e-05	0.000525	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CNR1—pancreatic cancer	3.97e-05	0.000521	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—KRAS—pancreatic cancer	3.96e-05	0.00052	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—DPYD—pancreatic cancer	3.95e-05	0.000519	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCKBR—pancreatic cancer	3.91e-05	0.000514	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—SST—pancreatic cancer	3.9e-05	0.000513	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	3.89e-05	0.000511	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—GCG—pancreatic cancer	3.83e-05	0.000503	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—SLC2A2—pancreatic cancer	3.75e-05	0.000493	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GLP1R—pancreatic cancer	3.75e-05	0.000492	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	3.7e-05	0.000486	CbGpPWpGaD
Amantadine—DDC—Metabolism—PIK3CG—pancreatic cancer	3.7e-05	0.000486	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	3.69e-05	0.000484	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—DPYD—pancreatic cancer	3.68e-05	0.000484	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GLI1—pancreatic cancer	3.68e-05	0.000483	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—DTX4—pancreatic cancer	3.68e-05	0.000483	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—AGTR1—pancreatic cancer	3.66e-05	0.00048	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CNR1—pancreatic cancer	3.6e-05	0.000473	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PRSS1—pancreatic cancer	3.59e-05	0.000472	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NRP1—pancreatic cancer	3.58e-05	0.00047	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PPP2R5B—pancreatic cancer	3.58e-05	0.00047	CbGpPWpGaD
Amantadine—DDC—Metabolism—PPARG—pancreatic cancer	3.57e-05	0.000469	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—SLC2A2—pancreatic cancer	3.5e-05	0.000459	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GCG—pancreatic cancer	3.48e-05	0.000457	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—HRAS—pancreatic cancer	3.46e-05	0.000454	CbGpPWpGaD
Amantadine—MAOB—Metabolism—APOE—pancreatic cancer	3.45e-05	0.000453	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	3.45e-05	0.000453	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HEY2—pancreatic cancer	3.45e-05	0.000452	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	3.42e-05	0.000449	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—TP53—pancreatic cancer	3.4e-05	0.000447	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—HRAS—pancreatic cancer	3.37e-05	0.000442	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GAST—pancreatic cancer	3.36e-05	0.000442	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	3.33e-05	0.000438	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AGTR1—pancreatic cancer	3.32e-05	0.000436	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	3.3e-05	0.000433	CbGpPWpGaD
Amantadine—DDC—Metabolism—PIK3CD—pancreatic cancer	3.25e-05	0.000427	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	3.22e-05	0.000422	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SCT—pancreatic cancer	3.19e-05	0.000419	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HEY1—pancreatic cancer	3.19e-05	0.000419	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ARG2—pancreatic cancer	3.12e-05	0.000409	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PIK3CG—pancreatic cancer	3.12e-05	0.000409	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—AKT1—pancreatic cancer	3.05e-05	0.000401	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCK—pancreatic cancer	3.04e-05	0.0004	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PPARG—pancreatic cancer	3.01e-05	0.000395	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.98e-05	0.000392	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—AKT1—pancreatic cancer	2.97e-05	0.000391	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CNR2—pancreatic cancer	2.97e-05	0.000389	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GLP1R—pancreatic cancer	2.97e-05	0.000389	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—CXCL8—pancreatic cancer	2.96e-05	0.000389	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCKAR—pancreatic cancer	2.92e-05	0.000383	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CD44—pancreatic cancer	2.91e-05	0.000381	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.9e-05	0.000381	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—HRAS—pancreatic cancer	2.84e-05	0.000373	CbGpPWpGaD
Amantadine—DDC—Metabolism—PIK3CB—pancreatic cancer	2.84e-05	0.000372	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—JAG2—pancreatic cancer	2.83e-05	0.000371	CbGpPWpGaD
Amantadine—DDC—Metabolism—PTGS2—pancreatic cancer	2.81e-05	0.000369	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MEN1—pancreatic cancer	2.79e-05	0.000366	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GCG—pancreatic cancer	2.79e-05	0.000366	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PIK3CD—pancreatic cancer	2.74e-05	0.00036	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—TYMP—pancreatic cancer	2.72e-05	0.000358	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CD44—pancreatic cancer	2.71e-05	0.000356	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.67e-05	0.000351	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.67e-05	0.00035	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SHH—pancreatic cancer	2.66e-05	0.000349	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—HRAS—pancreatic cancer	2.64e-05	0.000347	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NOTCH4—pancreatic cancer	2.64e-05	0.000347	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IAPP—pancreatic cancer	2.63e-05	0.000345	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—STK11—pancreatic cancer	2.62e-05	0.000344	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.61e-05	0.000343	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GCG—pancreatic cancer	2.6e-05	0.000341	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PTHLH—pancreatic cancer	2.52e-05	0.000331	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PTCH1—pancreatic cancer	2.52e-05	0.000331	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.49e-05	0.000327	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.47e-05	0.000324	CbGpPWpGaD
Amantadine—DDC—Metabolism—PTEN—pancreatic cancer	2.45e-05	0.000322	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—STK11—pancreatic cancer	2.44e-05	0.000321	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PIK3CB—pancreatic cancer	2.39e-05	0.000313	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PTGS2—pancreatic cancer	2.37e-05	0.000311	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SST—pancreatic cancer	2.31e-05	0.000303	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.27e-05	0.000299	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.27e-05	0.000298	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—JAG1—pancreatic cancer	2.26e-05	0.000296	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—TYMS—pancreatic cancer	2.25e-05	0.000296	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NOTCH3—pancreatic cancer	2.25e-05	0.000295	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GLP1R—pancreatic cancer	2.2e-05	0.000288	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.19e-05	0.000288	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—DPYD—pancreatic cancer	2.16e-05	0.000284	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CNR1—pancreatic cancer	2.13e-05	0.000279	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—TYMS—pancreatic cancer	2.1e-05	0.000276	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PIK3CG—pancreatic cancer	2.07e-05	0.000271	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PTEN—pancreatic cancer	2.06e-05	0.000271	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GCG—pancreatic cancer	2.06e-05	0.00027	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SLC2A2—pancreatic cancer	2.05e-05	0.000269	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PIK3CD—pancreatic cancer	2e-05	0.000263	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AGTR1—pancreatic cancer	1.96e-05	0.000257	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—STK11—pancreatic cancer	1.93e-05	0.000254	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.85e-05	0.000243	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—APOE—pancreatic cancer	1.83e-05	0.000241	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PIK3CD—pancreatic cancer	1.82e-05	0.000238	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.74e-05	0.000229	CbGpPWpGaD
Amantadine—DDC—Metabolism—PIK3CA—pancreatic cancer	1.73e-05	0.000227	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—APOE—pancreatic cancer	1.71e-05	0.000224	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SMAD4—pancreatic cancer	1.69e-05	0.000222	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CXCL8—pancreatic cancer	1.67e-05	0.00022	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PIK3CG—pancreatic cancer	1.65e-05	0.000217	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HES1—pancreatic cancer	1.65e-05	0.000217	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PPARG—pancreatic cancer	1.6e-05	0.00021	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CD44—pancreatic cancer	1.59e-05	0.000208	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PIK3CB—pancreatic cancer	1.58e-05	0.000208	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PIK3CG—pancreatic cancer	1.54e-05	0.000202	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GCG—pancreatic cancer	1.52e-05	0.0002	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CXCL8—pancreatic cancer	1.52e-05	0.0002	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PPARG—pancreatic cancer	1.49e-05	0.000195	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PIK3CA—pancreatic cancer	1.46e-05	0.000191	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PIK3CD—pancreatic cancer	1.45e-05	0.000191	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TERT—pancreatic cancer	1.45e-05	0.00019	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—STK11—pancreatic cancer	1.43e-05	0.000188	CbGpPWpGaD
Amantadine—DDC—Metabolism—AKT1—pancreatic cancer	1.41e-05	0.000185	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HIF1A—pancreatic cancer	1.39e-05	0.000182	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TSC2—pancreatic cancer	1.38e-05	0.000181	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PIK3CD—pancreatic cancer	1.35e-05	0.000178	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APOE—pancreatic cancer	1.35e-05	0.000178	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—KDR—pancreatic cancer	1.32e-05	0.000174	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PIK3CB—pancreatic cancer	1.27e-05	0.000166	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NFKBIA—pancreatic cancer	1.26e-05	0.000165	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PTGS2—pancreatic cancer	1.26e-05	0.000165	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NOTCH1—pancreatic cancer	1.25e-05	0.000164	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—TYMS—pancreatic cancer	1.23e-05	0.000162	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PIK3CG—pancreatic cancer	1.22e-05	0.00016	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—NRAS—pancreatic cancer	1.22e-05	0.00016	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EGF—pancreatic cancer	1.21e-05	0.000158	CbGpPWpGaD
Amantadine—MAOB—Metabolism—AKT1—pancreatic cancer	1.19e-05	0.000156	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PIK3CB—pancreatic cancer	1.18e-05	0.000155	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PTGS2—pancreatic cancer	1.17e-05	0.000154	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—EGFR—pancreatic cancer	1.11e-05	0.000146	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PTEN—pancreatic cancer	1.09e-05	0.000144	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PIK3CD—pancreatic cancer	1.07e-05	0.000141	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.06e-05	0.00014	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—KRAS—pancreatic cancer	1.05e-05	0.000138	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PTEN—pancreatic cancer	1.02e-05	0.000134	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOE—pancreatic cancer	1e-05	0.000131	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PIK3CA—pancreatic cancer	9.65e-06	0.000127	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PIK3CB—pancreatic cancer	9.35e-06	0.000123	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	9.03e-06	0.000119	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	8.98e-06	0.000118	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	8.93e-06	0.000117	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PPARG—pancreatic cancer	8.72e-06	0.000114	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	8.68e-06	0.000114	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CASP3—pancreatic cancer	8.6e-06	0.000113	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCND1—pancreatic cancer	8.37e-06	0.00011	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	8.29e-06	0.000109	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	8.13e-06	0.000107	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	8.08e-06	0.000106	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	7.94e-06	0.000104	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	7.88e-06	0.000103	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PIK3CA—pancreatic cancer	7.72e-06	0.000101	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SRC—pancreatic cancer	7.49e-06	9.84e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	7.3e-06	9.58e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	7.23e-06	9.49e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	7.21e-06	9.46e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PIK3CA—pancreatic cancer	7.2e-06	9.45e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	6.92e-06	9.09e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PTGS2—pancreatic cancer	6.86e-06	9e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MYC—pancreatic cancer	6.71e-06	8.82e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	6.7e-06	8.79e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	6.57e-06	8.62e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—AKT1—pancreatic cancer	6.31e-06	8.28e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	6.2e-06	8.15e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PTEN—pancreatic cancer	5.98e-06	7.85e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—AKT1—pancreatic cancer	5.88e-06	7.72e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	5.7e-06	7.48e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TP53—pancreatic cancer	5.51e-06	7.24e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	5.27e-06	6.92e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	4.66e-06	6.11e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	4.22e-06	5.54e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—AKT1—pancreatic cancer	3.45e-06	4.53e-05	CbGpPWpGaD
